Clinical trials
Prediabetic State trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
131 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 8 |
| 2014 | 1 |
| 2015 | 9 |
| 2016 | 9 |
| 2017 | 6 |
| 2018 | 6 |
| 2019 | 10 |
| 2020 | 11 |
| 2021 | 13 |
| 2022 | 14 |
| 2023 | 16 |
| 2024 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 131 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Toronto | 8 |
| John Sievenpiper | 6 |
| Medical University of Vienna | 4 |
| University of the Balearic Islands | 4 |
| Augusta University | 3 |
| Diabetes Foundation, India | 3 |
| Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey | 3 |
| University of Guadalajara | 3 |
| Chinese University of Hong Kong | 2 |
| German Institute of Human Nutrition | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prediabetic State | 131 |
| Obesity | 39 |
| Diabetes Mellitus, Type 2 | 25 |
| Diabetes Mellitus | 23 |
| Insulin Resistance | 20 |
| Overweight | 17 |
| Cardiovascular Diseases | 15 |
| Metabolic Syndrome | 14 |
| Dyslipidemias | 13 |
| Body Weight | 11 |
Trials
Showing 51 to 75 of 131. Each trial links to its page on Pharma Observatory.
31 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.